200 related articles for article (PubMed ID: 28445952)
1. SOCS3 inhibits the pathological effects of IL-22 in non-melanoma skin tumor-derived keratinocytes.
Madonna S; Scarponi C; Morelli M; Sestito R; Scognamiglio PL; Marasco D; Albanesi C
Oncotarget; 2017 Apr; 8(15):24652-24667. PubMed ID: 28445952
[TBL] [Abstract][Full Text] [Related]
2. Rapid Inflammation in Mice Lacking Both SOCS1 and SOCS3 in Hematopoietic Cells.
Ushiki T; Huntington ND; Glaser SP; Kiu H; Georgiou A; Zhang JG; Metcalf D; Nicola NA; Roberts AW; Alexander WS
PLoS One; 2016; 11(9):e0162111. PubMed ID: 27583437
[TBL] [Abstract][Full Text] [Related]
3. Suppressors of Cytokine Signaling (SOCS)1 and SOCS3 Proteins Are Mediators of Interleukin-10 Modulation of Inflammatory Responses Induced by
Duncan SA; Sahu R; Dixit S; Singh SR; Dennis VA
Mediators Inflamm; 2020; 2020():7461742. PubMed ID: 32684836
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of SOCS3 and its biological function in colorectal cancer.
Chu Q; Shen D; He L; Wang H; Liu C; Zhang W
Gene; 2017 Sep; 627():114-122. PubMed ID: 28603075
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor-binding protein-7 (IGFBP7) transcript: A-to-I editing events in normal and cancerous human keratinocytes.
Hochberg M; Gilead L; Markel G; Nemlich Y; Feiler Y; Enk CD; Denichenko P; Karni R; Ingber A
Arch Dermatol Res; 2013 Aug; 305(6):519-28. PubMed ID: 23543219
[TBL] [Abstract][Full Text] [Related]
6. Mimetics of suppressor of cytokine signaling 3: Novel potential therapeutics in triple breast cancer.
La Manna S; Lee E; Ouzounova M; Di Natale C; Novellino E; Merlino A; Korkaya H; Marasco D
Int J Cancer; 2018 Nov; 143(9):2177-2186. PubMed ID: 29752723
[TBL] [Abstract][Full Text] [Related]
7. Dysregulation of suppressor of cytokine signaling 3 in keratinocytes causes skin inflammation mediated by interleukin-20 receptor-related cytokines.
Uto-Konomi A; Miyauchi K; Ozaki N; Motomura Y; Suzuki Y; Yoshimura A; Suzuki S; Cua D; Kubo M
PLoS One; 2012; 7(7):e40343. PubMed ID: 22792286
[TBL] [Abstract][Full Text] [Related]
8. Human primary keratinocytes show restricted ability to up-regulate suppressor of cytokine signaling (SOCS)3 protein compared with autologous macrophages.
Zeitvogel J; Dalpke A; Eiz-Vesper B; Kracht M; Dittrich-Breiholz O; Werfel T; Wittmann M
J Biol Chem; 2012 Mar; 287(13):9923-9930. PubMed ID: 22294695
[TBL] [Abstract][Full Text] [Related]
9. Anti-apoptotic effects of suppressor of cytokine signaling 3 and 1 in psoriasis.
Madonna S; Scarponi C; Pallotta S; Cavani A; Albanesi C
Cell Death Dis; 2012 Jun; 3(6):e334. PubMed ID: 22739986
[TBL] [Abstract][Full Text] [Related]
10. CCR5 Blockade Suppresses Melanoma Development Through Inhibition of IL-6-Stat3 Pathway via Upregulation of SOCS3.
Tang Q; Jiang J; Liu J
Inflammation; 2015 Dec; 38(6):2049-56. PubMed ID: 26047948
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic Potential for Targeting the Suppressor of Cytokine Signalling-1 Pathway for the Treatment of SLE.
Sukka-Ganesh B; Larkin J
Scand J Immunol; 2016 Nov; 84(5):299-309. PubMed ID: 27781323
[TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase-dependent signaling is causally linked to non-melanoma skin carcinogenesis: pharmacological, genetic, and clinical evidence.
Müller-Decker K
Cancer Metastasis Rev; 2011 Dec; 30(3-4):343-61. PubMed ID: 22038018
[TBL] [Abstract][Full Text] [Related]
13. Cell type specific interleukin-6 induced responses in tumor keratinocytes and stromal fibroblasts are essential for invasive growth.
Depner S; Lederle W; Gutschalk C; Linde N; Zajonz A; Mueller MM
Int J Cancer; 2014 Aug; 135(3):551-62. PubMed ID: 23165423
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of interleukin-6 in human basal cell carcinoma cell lines increases anti-apoptotic activity and tumorigenic potency.
Jee SH; Shen SC; Chiu HC; Tsai WL; Kuo ML
Oncogene; 2001 Jan; 20(2):198-208. PubMed ID: 11313947
[TBL] [Abstract][Full Text] [Related]
15. The suppressor of cytokine signaling (SOCS)-3 determines keratinocyte proliferative and migratory potential during skin repair.
Linke A; Goren I; Bösl MR; Pfeilschifter J; Frank S
J Invest Dermatol; 2010 Mar; 130(3):876-85. PubMed ID: 19924142
[TBL] [Abstract][Full Text] [Related]
16. Radiotherapy resistance acquisition in Glioblastoma. Role of SOCS1 and SOCS3.
Ventero MP; Fuentes-Baile M; Quereda C; Perez-Valeciano E; Alenda C; Garcia-Morales P; Esposito D; Dorado P; Manuel Barbera V; Saceda M
PLoS One; 2019; 14(2):e0212581. PubMed ID: 30811476
[TBL] [Abstract][Full Text] [Related]
17. RING protein Trim32 associated with skin carcinogenesis has anti-apoptotic and E3-ubiquitin ligase properties.
Horn EJ; Albor A; Liu Y; El-Hizawi S; Vanderbeek GE; Babcock M; Bowden GT; Hennings H; Lozano G; Weinberg WC; Kulesz-Martin M
Carcinogenesis; 2004 Feb; 25(2):157-67. PubMed ID: 14578165
[TBL] [Abstract][Full Text] [Related]
18. PKK deletion in basal keratinocytes promotes tumorigenesis after chemical carcinogenesis.
Chen L; Hayden MS; Gilmore ES; Alexander-Savino C; Oleksyn D; Gillespie K; Zhao J; Poligone B
Carcinogenesis; 2018 Mar; 39(3):418-428. PubMed ID: 29186361
[TBL] [Abstract][Full Text] [Related]
19. Expression of the anti-inflammatory suppressor of cytokine signaling 3 (SOCS3) in human clear cell renal cell carcinoma.
Urbschat A; Stumpf S; Hänze J; Paulus P; Maier TJ; Weipert C; Hofmann R; Hegele A
Tumour Biol; 2016 Jul; 37(7):9649-56. PubMed ID: 26797799
[TBL] [Abstract][Full Text] [Related]
20. Human β-defensin-2 enhances IFN-γ and IL-10 production and suppresses IL-17 production in T cells.
Kanda N; Kamata M; Tada Y; Ishikawa T; Sato S; Watanabe S
J Leukoc Biol; 2011 Jun; 89(6):935-44. PubMed ID: 21367976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
